Browsing by Author Li, Lanfang
Showing results 1 to 3 of 3
| Issue Date | Title | Author(s) |
| Sep-2021 | Improved method to stratify lymphoma patients with risk of secondary central nervous system involvement: A multicenter retrospective analysis | Lang, Mingxiao; Feng, Youqin; Meng, Xiangrui; Zhao, Jing; Song, Zheng; Qian, Zhengzi; Qiu, Lihua; Zhou, Shiyong; Liu, Xianming; Li, Lanfang; Yang, Haiyan; Song, Yuqin; Li, Wei; Zhang, Huilai |
| 2-Nov-2023 | Phase 2 Search Study:XPO1 Inhibitor (ATG-010) Monotherapy in Heavily Pretreated Chinese Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma | Song, Yuqin; Cai, Qingqing; Zhang, Qingyuan; Sun, Xiuhua; Yang, Haiyan; Yao, Zhihua; Zou, Liqun; Zhang, Liling; Cao, Junning; Wang, Tingyu; Li, Lanfang; Liu, Yao; Jing, Hongmei; Gao, Sujun; Ding, Kaiyang; Liu, Bingshan; Zhao, Jun; Zhu, Jun |
| 26-Sep-2024 | Time to lymphoma treatment within 24 months in 'watch and wait' follicular lymphoma is associated with inferior outcomes: A multicentre analysis | Liu, Jing; Gao, Fenghua; Zhang, Tingting; Wang, Jiesong; Li, Zhiming; Liu, Lihong; Zhou, Hui; Zhang, Xudong; Sun, Xiuhua; Zhang, Wei; Xu, Bing; Su, Liping; Wen, Shujuan; Tao, Rong; Bai, Ou; Zou, Liqun; Li, Lanfang; Qiu, Lihua; Qian, Zhengzi; Zhou, Shiyong; Song, Yuqin; Zhang, Qingyuan; Wang, Xianhuo; Zhang, Huilai |
